(adding content) |
|||
| Line 22: | Line 22: | ||
<br> | <br> | ||
<br> | <br> | ||
<br> | |||
<br> | |||
==Steven Schroeder== | ==Steven Schroeder== | ||
| Line 37: | Line 40: | ||
<br> | <br> | ||
<br> | <br> | ||
==Mitch Zeller, JD== | ==Mitch Zeller, JD== | ||
[[File:Mitch_Zeller_JD.jpg|thumb|left|FDA]]<br> | [[File:Mitch_Zeller_JD.jpg|thumb|left|FDA]]<br> | ||
| Line 47: | Line 54: | ||
[https://www.fda.gov/tobacco-products/about-center-tobacco-products-ctp/mitch-zeller?fbclid=IwAR1ojQX5R9fwtq0fu5QX1EKSQVhLJ2C1LpWJh7QnQUBPygI-JeBSU7JIPUM#Bio Zeller, a graduate of Dartmouth College and the American University Washington College of Law], has been working on FDA issues for more than 30 years. He began his career as a public interest attorney in 1982 at the Center for Science in the Public Interest (CSPI). In 1988, Zeller left CSPI to become counsel to the Human Resources and Intergovernmental Relations Subcommittee of the House of Representatives Government Operations Committee where he conducted oversight of enforcement of federal health and safety laws. Instrumental in crafting the FDA's 1996 tobacco regulations, Zeller also represented FDA before Congress, federal and state agencies. Zeller also served as an official U.S. delegate to the World Health Organization (WHO) Working Group for the Framework Convention on Tobacco Control. | [https://www.fda.gov/tobacco-products/about-center-tobacco-products-ctp/mitch-zeller?fbclid=IwAR1ojQX5R9fwtq0fu5QX1EKSQVhLJ2C1LpWJh7QnQUBPygI-JeBSU7JIPUM#Bio Zeller, a graduate of Dartmouth College and the American University Washington College of Law], has been working on FDA issues for more than 30 years. He began his career as a public interest attorney in 1982 at the Center for Science in the Public Interest (CSPI). In 1988, Zeller left CSPI to become counsel to the Human Resources and Intergovernmental Relations Subcommittee of the House of Representatives Government Operations Committee where he conducted oversight of enforcement of federal health and safety laws. Instrumental in crafting the FDA's 1996 tobacco regulations, Zeller also represented FDA before Congress, federal and state agencies. Zeller also served as an official U.S. delegate to the World Health Organization (WHO) Working Group for the Framework Convention on Tobacco Control. | ||
<br> | |||
==Tom Miller== | ==Tom Miller== | ||
[[File:Iowa_AG_Tom_Miller.jpg |thumb|right|Iowa Attorney General]]<br> | [[File:Iowa_AG_Tom_Miller.jpg |thumb|right|Iowa Attorney General]]<br> | ||
'''The harm of the combustible cigarette is dramatically greater than the harm of the e-cigarette''' | '''The harm of the combustible cigarette is dramatically greater than the harm of the e-cigarette''' | ||
| Line 57: | Line 71: | ||
He was actively involved in the establishment of the Tobacco Master Settlement Agreement and has been a fierce and determined critic of the Tobacco Industry over many years. [https://safernicotine.wiki/mediawiki/index.php/Tom_Miller Tom Miller served on the Board of the Truth Initiative (American Legacy Foundation)] | He was actively involved in the establishment of the Tobacco Master Settlement Agreement and has been a fierce and determined critic of the Tobacco Industry over many years. [https://safernicotine.wiki/mediawiki/index.php/Tom_Miller Tom Miller served on the Board of the Truth Initiative (American Legacy Foundation)] | ||
<br> | |||
<br> | |||
<br> | |||
| Line 82: | Line 100: | ||
<br> | <br> | ||
<br> | <br> | ||
==Thomas Brandon, PhD== | |||
[[File:Thomas_Brandon_PhD.jpg|thumb|left|Moffitt Cancer Center]]<br> | |||
Earlier this year, the findings from a major clinical trial, published in the New England Journal of Medicine, showed that e-cigarettes were almost twice as effective as the nicotine patch for producing one year of smoking cessation. These findings added to those of other, smaller studies previously published. | |||
“[https://moffitt.org/newsroom/press-release-archive/2019/moffitt-cancer-center-studies-how-e-cigarettes-help-smokers-quit/ This could be a game-changer for lots of people,” says Thomas Brandon, Ph.D]., director of Moffitt’s Tobacco Research and Intervention Program and chair of the Department of Health Outcomes and Behavior. “It means that for smokers who have not been able to quit by using the available medications, vaping might be worth a try. But it is important to completely switch from smoking to vaping to get the most health benefits.” | |||
[https://moffitt.org/research-science/research-teams/tobacco-research-and-intervention-program-trip/meet-the-trip-team/#:~:text=Thomas%20Brandon%2C%20PhD%2C%20is%20the,Behavior%20at%20Moffitt%20Cancer%20Center.&text=With%20interventions%2C%20he%20has%20concentrated,treatments%20and%20self%2Dhelp%20interventions. Thomas Brandon, PhD, is the Director of the Tobacco Research and Intervention Program] and Chair of the Department of Health Outcomes and Behavior at Moffitt Cancer Center. He is also Professor of Psychology and Oncologic Sciences at the University of South Florida | |||
edits